BLC
ALNY icon

Brown, Lisle/Cummings’s Alnylam Pharmaceuticals ALNY Stock Holding History

Brown, Lisle/Cummings’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53.6K Buy
162
+30
+23% +$10.2K 0.01% 350
2025
Q4 		$52.5K Hold
132
– – 0.01% 338
2025
Q3 		$60.2K Hold
132
– – 0.02% 323
2025
Q2 		$43K Hold
132
– – 0.01% 350
2025
Q1 		$35.6K Buy
132
+7
+6% +$1.8K 0.01% 361
2024
Q4 		$29.4K Hold
125
– – 0.01% 375
2024
Q3 		$34.4K Hold
125
– – 0.01% 346
2024
Q2 		$30.4K Hold
125
– – 0.01% 350
2024
Q1 		$18.7K Hold
125
– – 0.01% 378
2023
Q4 		$23.9K Hold
125
– – 0.01% 346
2023
Q3 		$22.1K Hold
125
– – 0.01% 329
2023
Q2 		$23.7K Hold
125
– – 0.01% 325
2023
Q1 		$25K Hold
125
– – 0.01% 317
2022
Q4 		$29.7K Buy
+125
New +$26.7K 0.02% 298

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return